10 results
Recommendations for specific antimicrobial therapy in bacterial meningitis based on isolated pathogen and susceptibility testing.

#IDSA #Meningitis
therapy in bacterial meningitis ... #IDSA #Meningitis ... Pathogens #Isolated #InfectiousDiseases ... #Pharmacology # ... Management
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
therapy for purulent meningitis ... condition #IDSA #Meningitis ... Empiric #Coverage #InfectiousDiseases ... #Pharmacology # ... Management
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
• Hepatitis A virus ... • Hepatitis B virus ... Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
• Hepatitis A virus ... • Hepatitis B virus ... Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
chronic hepatitis C virus ... #medications #infectiousdisease ... HepC #HepatitisC #Management ... #Pharmacology
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
- Bacterial meningitis ... - Tuberculous meningitis ... Corticosteroids #Adjuvant #InfectiousDiseases ... #Infections #Pharmacology ... #Management #Treatment
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
SARS-CoV-2, the virus ... Pandemic #Outbreak #InfectiousDiseases ... EmergencyMedicine #Pharmacology ... #Treatment #Virus ... #Antiviral #Management
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
Immunodeficiency Virus ... IDSA #Treatment #management ... #meningitis #cryptococcus ... #HIVAIDS
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
Herpes Simplex Virus ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
Varicella Zoster Virus ... because of vaccine virus ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology